Todd McAdams

Todd McAdams has a strong background in the field of biological engineering. Todd started their career as the Founder and CEO of Tissue Therapeutics Inc., where they focused on the development of single-use perfusion bioreactors for research and therapeutic purposes. In 2001, the company was acquired by Resodyn Corporation. At Resodyn Corporation, Todd served as the Chief Biological Engineer and was responsible for leading the scientific and engineering aspects of biotechnology development. Todd specialized in bioreactor design, development, and optimization, with expertise in hematopoietic stem cell culture and applications. Todd recently joined BioSqueeze Inc. as the Chief Biological Engineer, continuing their work in the field of biological engineering.

Todd McAdams has a strong educational background in the field of Chemical Engineering. Todd began their education journey at the University of Colorado Boulder in 1986 and completed their Bachelor of Science degree in Chemical Engineering in 1991. Following this, they pursued a Master of Science degree in Chemical Engineering at Caltech from 1991 to 1992. Todd then continued their academic pursuits by enrolling in Northwestern University, where they obtained their Ph.D. in Chemical Engineering from 1992 to 1997.